13F filer · CIK 1131399
GSK plc
London, X0 · filing since Q4 2025 · last filing Nov 5, 2026
Reported value
$497.0M
$-105.2M vs prior
Positions
13
New / sold out
1 / 1
Added / reduced
0 / 2
Turnover
12.3%
buys $67.5M · sells $161.6M
Top-10 weight
98.1%
Biggest buys vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | WAVE LIFE SCIENCES INC | +18,245,691 | – | +$67.5M |
Biggest sells vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | WAVE LIFE SCIENCES LTD | -18,245,691 | -100.0% | $-106.0M |
| Reduced | CRISPR THERAPEUTICS AG | -612,208 | -19.0% | $-33.9M |
| Reduced | BIONTECH SE | -221,298 | -24.9% | $-21.8M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CRISPR THERAPEUTICS AGNAMEN AKT | 2,608,419 | $144.3M | 29.03% |
| 2 | VIR BIOTECHNOLOGY INCCOM | 8,550,954 | $95.6M | 19.23% |
| 3 | WAVE LIFE SCIENCES INCSHS | 18,245,691 | $67.5M | 13.58% |
| 4 | BIONTECH SESPONSORED ADS | 668,526 | $65.7M | 13.22% |
| 5 | IDEAYA BIOSCIENCES INCCOM | 1,333,333 | $51.2M | 10.31% |
| 6 | CYTOKINETICS INCCOM NEW | 340,434 | $22.4M | 4.51% |
| 7 | LYELL IMMUNOPHARMA INCCOM NEW | 1,512,659 | $14.8M | 2.98% |
| 8 | SPERO THERAPEUTICS INCCOM | 9,190,606 | $11.1M | 2.24% |
| 9 | NKARTA INCCOM | 3,150,732 | $8.3M | 1.66% |
| 10 | FULCRUM THERAPEUTICS INCCOM | 1,785,714 | $6.6M | 1.33% |
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.